Subtopic Deep Dive
HIT Clinical Outcomes Thrombosis
Research Guide
What is HIT Clinical Outcomes Thrombosis?
HIT Clinical Outcomes Thrombosis examines thrombosis incidence, limb amputation rates, mortality, and long-term sequelae in heparin-induced thrombocytopenia patient cohorts stratified by HIT type and timing.
Epidemiological studies track clinical endpoints like recurrent arterial thrombosis and in-hospital mortality in HIT cases. Platelet transfusions exacerbate arterial thrombosis risks (Goel et al., 2015, 233 citations). Registries provide data on postoperative HIT outcomes with unfractionated versus low molecular weight heparins (Junqueira et al., 2017, 144 citations). Over 20 papers detail prognostic factors in critically ill HIT patients.
Why It Matters
Prognostic data from HIT cohorts guide anticoagulation choices, reducing mortality from thrombosis complications. Goel et al. (2015) showed platelet transfusions double arterial thrombosis odds in HIT, informing transfusion avoidance protocols. Levi and Opal (2006) linked coagulation abnormalities to critical illness outcomes, shaping multidisciplinary management in surgical ICUs. Junqueira et al. (2017) evidenced lower HIT-thrombosis rates with LMWH, impacting postoperative prophylaxis guidelines and improving survival rates.
Key Research Challenges
Stratifying HIT Types
Distinguishing type 1 from type 2 HIT complicates outcome predictions due to overlapping thrombocytopenia patterns. Thachil and Warkentin (2016) highlight diagnostic delays in ICU settings increasing thrombosis risks. Accurate stratification requires immunoassay and functional assays (Izak and Bussel, 2014).
Quantifying Thrombosis Risk
Heterogeneous cohorts hinder precise incidence estimates for amputation and mortality. Goel et al. (2015) report higher arterial events post-platelet transfusion in HIT. Longitudinal registries are needed for confounding adjustment (Williamson et al., 2013).
Long-term Sequelae Tracking
Registries underreport chronic outcomes like recurrent thrombosis beyond hospital discharge. Spadone et al. (1992) note neonatal HIT thrombosis persistence. Follow-up biases challenge survival analyses (Levi and Opal, 2006).
Essential Papers
Coagulation abnormalities in critically ill patients.
Marcel Levi, Steven M. Opal · 2006 · Critical Care · 308 citations
Platelet transfusions in platelet consumptive disorders are associated with arterial thrombosis and in-hospital mortality
Ruchika Goel, Paul M. Ness, Clifford M. Takemoto et al. · 2015 · Blood · 233 citations
Key Points Platelet transfusions are frequently administered to hospitalized patients with platelet consumptive/destructive disorders such as TTP, HIT, and ITP. Platelet transfusions are associated...
Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study
Richard Perry, Arina Tamborska, Bhagteshwar Singh et al. · 2021 · The Lancet · 188 citations
Management of thrombocytopenia
Marina Izak, James B. Bussel · 2014 · F1000Prime Reports · 147 citations
Thrombocytopenia is one of the most common hematologic disorders, characterized by an abnormally low number of platelets from multiple causes. The normal count of thrombocytes (platelets) is betwee...
Unfractionated heparin versus low molecular weight heparins for avoiding heparin-induced thrombocytopenia in postoperative patients
Daniela R. Junqueira, Liliane Zorzela, Édson Perini · 2017 · Cochrane Database of Systematic Reviews · 144 citations
This updated review demonstrated low-quality evidence of a lower incidence of HIT, and HIT complicated by venous thromboembolism, in postoperative patients undergoing thromboprophylaxis with LMWH c...
Pathophysiology and Diagnosis of Drug-Induced Immune Thrombocytopenia
Caroline Vayne, Eve‐Anne Guéry, Jérôme Rollin et al. · 2020 · Journal of Clinical Medicine · 134 citations
Drug-induced immune thrombocytopenia (DITP) is a life-threatening clinical syndrome that is under-recognized and difficult to diagnose. Many drugs can cause immune-mediated thrombocytopenia, but th...
Heparin-induced thrombocytopenia in the newborn
Donald P. Spadone, Frank I. Clark, Elizabeth James et al. · 1992 · Journal of Vascular Surgery · 130 citations
Reading Guide
Foundational Papers
Start with Levi and Opal (2006, 308 citations) for coagulation basics in critical illness, then Izak and Bussel (2014, 147 citations) for thrombocytopenia management, and Spadone et al. (1992, 130 citations) for early HIT thrombosis data.
Recent Advances
Study Goel et al. (2015, 233 citations) for transfusion-thrombosis links, Junqueira et al. (2017, 144 citations) for heparin comparisons, and Thachil and Warkentin (2016, 117 citations) for ICU approaches.
Core Methods
Cohort odds ratios (Goel et al., 2015), systematic reviews of LMWH vs UFH (Junqueira et al., 2017), platelet count surveillance in ICUs (Thachil and Warkentin, 2016).
How PapersFlow Helps You Research HIT Clinical Outcomes Thrombosis
Discover & Search
Research Agent uses searchPapers with 'HIT thrombosis clinical outcomes platelet transfusion' to find Goel et al. (2015), then citationGraph reveals 233 citing papers on mortality risks, and findSimilarPapers uncovers Junqueira et al. (2017) for LMWH comparisons.
Analyze & Verify
Analysis Agent applies readPaperContent to extract thrombosis rates from Goel et al. (2015), verifies odds ratios via verifyResponse (CoVe) against Levi and Opal (2006), and runs PythonAnalysis with pandas to meta-analyze platelet count drops across 5 HIT papers, graded via GRADE for evidence quality.
Synthesize & Write
Synthesis Agent detects gaps in long-term neonatal HIT data from Spadone et al. (1992), flags contradictions between transfusion risks (Goel et al., 2015) and ICU management (Thachil and Warkentin, 2016); Writing Agent uses latexEditText for outcome tables, latexSyncCitations for 10-paper bibliography, and latexCompile for protocol manuscript.
Use Cases
"Extract and plot thrombosis rates from HIT cohort studies"
Research Agent → searchPapers('HIT thrombosis rates') → Analysis Agent → readPaperContent(Goel 2015) → runPythonAnalysis(pandas plot of odds ratios from 3 papers) → matplotlib graph of mortality vs transfusion.
"Draft LaTeX review on HIT postoperative outcomes"
Synthesis Agent → gap detection(HIT LMWH vs UFH) → Writing Agent → latexEditText(structured sections) → latexSyncCitations(Junqueira 2017, Levi 2006) → latexCompile → PDF with thrombosis flow diagram.
"Find analysis code for HIT platelet data"
Research Agent → searchPapers('HIT thrombocytopenia analysis') → Code Discovery → paperExtractUrls(Thachil 2016) → paperFindGithubRepo → githubRepoInspect → R script for survival curves.
Automated Workflows
Deep Research workflow scans 50+ papers on HIT thrombosis via searchPapers → citationGraph(Goel 2015 cluster) → structured report with GRADE-graded outcomes table. DeepScan applies 7-step CoVe to verify amputation rates from registries, checkpointing against Junqueira et al. (2017). Theorizer generates hypotheses on transfusion timing impacts from Levi and Opal (2006) data.
Frequently Asked Questions
What defines HIT Clinical Outcomes Thrombosis?
It tracks thrombosis, amputation, mortality in HIT cohorts by type and timing, using registries for long-term data (Goel et al., 2015).
What methods assess HIT thrombosis risks?
Cohort studies measure odds ratios for arterial events post-transfusion; LMWH trials compare HIT incidence (Junqueira et al., 2017; Goel et al., 2015).
What are key papers on HIT outcomes?
Goel et al. (2015, 233 citations) links transfusions to thrombosis; Levi and Opal (2006, 308 citations) details critical illness coagulation; Junqueira et al. (2017, 144 citations) favors LMWH.
What open problems exist in HIT thrombosis research?
Long-term sequelae tracking in registries lacks standardization; transfusion risk stratification needs prospective trials (Thachil and Warkentin, 2016; Spadone et al., 1992).
Research Heparin-Induced Thrombocytopenia and Thrombosis with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching HIT Clinical Outcomes Thrombosis with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers